<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019408</url>
  </required_header>
  <id_info>
    <org_study_id>NH-HNI01</org_study_id>
    <nct_id>NCT01019408</nct_id>
  </id_info>
  <brief_title>Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan</brief_title>
  <acronym>ECQNWFP</acronym>
  <official_title>Clinical Trial of Extended-dose Chloroquine Versus Standard Chloroquine Treatment for Resistant Falciparum Malaria Among Afghan Refugees in NWFP Pakistan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United Nations High Commissioner for Refugees</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Health Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>London School of Hygiene and Tropical Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to provide stronger evidence for extended-dose chloroquine
      treatment of falciparum-positive Afghan refugees in Northwest Frontier Province (NWFP),
      Pakistan or justification for discontinuation of the policy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine whether extended-dose chloroquine provided better cure rates and fewer
      recrudescences than standard chloroquine treatment among Afghan refugees, 163 falciparum
      patients from three Afghan refugee camps were recruited into 3-day (CQ 25mg/kg) or 5-day (CQ
      40mg/kg) treatment arms and followed for up to 60 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 1993</start_date>
  <completion_date type="Actual">January 1995</completion_date>
  <primary_completion_date type="Actual">January 1995</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>therapeutic and parasitological cure with no recrudescence</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>parasite clearance time</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fever clearance time</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gametocytaemia</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">163</enrollment>
  <condition>Malaria, Falciparum</condition>
  <arm_group>
    <arm_group_label>CQ25</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Falciparum positive patients receiving standard 3-day treatment course of CQ 25mg/kg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CQ40</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Falciparum positive patients receiving a 5-day treatment course of CQ 40 mg/kg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chloroquine</intervention_name>
    <description>Comparison of two different dosages of chloroquine for treatment of falciparum malaria in Afghan refugee camps in Northwest Frontier Province, Pakistan</description>
    <arm_group_label>CQ25</arm_group_label>
    <arm_group_label>CQ40</arm_group_label>
    <other_name>CQ</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  slide-confirmed infection with P. falciparum only

          -  initial parasite density of 1000-100,000 asexual parasites/μl

          -  absence of severe malnutrition

          -  ability to attend stipulated follow-up visits and easy access to facility

          -  informed consent provided by patient or parent/guardian

          -  absence of history of hypersensitivity reactions to CQ

        Exclusion Criteria:

          -  infants under six months old

          -  pregnancy or lactation

          -  underlying chronic severe illness

          -  patients with other febrile illnesses

          -  parasitaemia outside the range of 1000-100,000 asexual parasites/µl

          -  severe malaria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Rowland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LSHTM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adezai Basic Health Unit</name>
      <address>
        <city>Adezai</city>
        <state>Nwfp</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baghicha Basic Health Unit</name>
      <address>
        <city>Baghicha</city>
        <state>Nwfp</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kagan Basic Health Unit</name>
      <address>
        <city>Kagan</city>
        <state>Nwfp</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2009</study_first_submitted>
  <study_first_submitted_qc>November 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>November 23, 2009</last_update_submitted>
  <last_update_submitted_qc>November 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Mark Rowland</name_title>
    <organization>LSHTM</organization>
  </responsible_party>
  <keyword>Clinical Trial</keyword>
  <keyword>Chloroquine</keyword>
  <keyword>Refugees</keyword>
  <keyword>Afghanistan</keyword>
  <keyword>Pakistan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Malaria, Falciparum</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chloroquine</mesh_term>
    <mesh_term>Chloroquine diphosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

